Bone tissue metabolism in men with ankylosing spondylitis

Advances in Medical Sciences

Volumn 56, Issue 2, 2011, Pages 264-269

  Korczowska, I ^a   Przepiera Bedzak, H ^b   Brzosko, M ^b   Lacki, J K ^c   Trefler, J ^d   Hrycaj, P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF ZIELONA GÓRA   (Poland)

^d INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

ankylosing spondylitis; cytokines; densitometry; makers of osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; BONE FRACTION OF AN ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CALCIUM; COLECALCIFEROL; CORTICOSTEROID; CYTOKINE; DEOXYPYRIDINOLINE; INTERLEUKIN 6; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCALCIN; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD SAMPLING; BONE DEFECT; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TISSUE; BONE TISSUE METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FOREARM; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMOBILIZATION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPONDYLOARTHROPATHY;

EID: 84855436437     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-011-0049-4     Document Type: Article

References (24)

1. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001 Jun;60(6):619-26. (Pubitemid 32493990)
2. Moll JM, Wright V. New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis. 1973 Jul;32(4):354-63.
3. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defning disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994 Dec;21(12):2286-91.
4. El Maghraoui A, Borderie D, Cherruau B, Edouard R, Dougados M, Roux C. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol. 1999 Oct;26(10):2205-9. (Pubitemid 29487018)
5. Meirelles ES, Borelli A, Camargo OP. Infuence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol. 1999;18(5):364-8. (Pubitemid 29479763)
6. Mitra D, Elvins DM, Speden DJ, Collins AJ. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology (Oxford). 2000 Jan;39(1):85-9. (Pubitemid 30095412)
7. Baek HJ, Kang SW, Lee YJ, Shin KC, Lee EB, Yoo CD, Song YW. Osteopenia in men with mild and severe ankylosing spondylitis. Rheumatol Int. 2005 Nov;26(1):30-4. (Pubitemid 41531511)
8. Bronson WD, Walker SE, Hillman LS, Keisler D, Hoyt T, Allen SH. Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol. 1998 May;25(5):929-35. (Pubitemid 28210558)
9. Singh A, Bronson W, Walker SE, Allen SH. Relative value of femoral and lumbar bone mineral density assessments in patients with ankylosing spondylitis. South Med J. 1995 Sep;88(9):939-43.
10. Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford). 2001 Aug;40(8):882-8.
11. Reid DM, Nicoll JJ, Kennedy NS, Smith MA, Tothill P, Nuki G. Bone mass in ankylosing spondylitis. J Rheumatol 1986 Oct;13(5):932-5. (Pubitemid 17203929)
12. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J; Committee of Scientifc Advisors of the International Osteoporosis Foundation]. The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientifc Advisors of the International Osteoporosis Foundation. Osteoporos Int. 2000;11 Suppl 6:S2-17.
13. Masud T, Langley S, Wiltshire P, Doyle DV, Spector TD. Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ 1993 Jun;307(6897):172-3. (Pubitemid 23199981)
14. Szejnfeld VL, Monier-Faugere MC, Bognar BJ, Ferraz MB, Malluche HH. Systemic osteopenia and mineralization defect in patients with ankylosing spondylitis. J Rheumatol. 1997 Apr;24(4):683-8. (Pubitemid 27146085)
15. Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal, Bezza A, El Maghraoui A. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009 May;44(5):772-6.
16. Yilmaz N, Ozaslan J. Biochemical bone turnover markers in patients with ankylosing spondylitis. Clin Rheumatol. 2000;19(2):92-8. (Pubitemid 30236137)
17. Min-Chan Park, Soo-Jin Chung, Yong-Beom Park and Soo-Kon Lee. Bone and cartilage turnover markers, bone mineral density and radiographic damage in men with ankylosing spondylitis. Yonsei Med J. 2008 Apr;49(2):288-94. (Pubitemid 351781179)
18. Marhoffer W, Stracke H, Masoud I. Evidence of impaired cartilage bone turnover in patients with active ankylosing spondylitis. Ann Rheum Dis 1995 Jul;54(7):556-9.
19. Toussirot E, Ricard-Blum S, Dumoulin G, Cedoz JP, Wendling D. Relationship between urinary pyridinium cross-links, disease activity and disease subset of ankylosing spondylitis. Rheumatology (Oxford). 1999 Jan;38(1):21-7. (Pubitemid 29509652)
20. Sarikaya S, Basaran A, Tekin Y Ozdolap S, Ortancil O. Is osteoporosis generalized or localized to central skeleton in ankylosing spondylitis?. J Clin Rheumatol. 2007 Feb;13(1):20-4. (Pubitemid 46213838)
21. Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KL. Association of 1.25 vitamin D3 defcienty, disease activity and low bone mass in ankylosing spondylitis. Osteoporosis Int. 2005 Dec;16(12):1999-2004. (Pubitemid 41790919)
22. Franck H, Keck E. Serum osteocalcin and vitamin-D metabolites in patients with ankylosing spondylitis. Ann Rheum Dis 1993 May;52(5):343-6. (Pubitemid 23165971)
23. Shehan NJ, Slavin BM, Kind PR, Mathews JA. Increased serum alkaline phosphatase activity in ankylosing spondylitis. Ann Rheum Dis. 1983 Oct;42(5):563-5. (Pubitemid 13016031)
24. Siede WH, Seiffert UB, Merle S, Goll HG, Oremek G. Alkaline phosphatase isoenzymes in rheumatic diseases. Clin Biochem. 1989 Apr;22(2):121-4 (Pubitemid 19121442)